BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 30170274)

  • 1. Investigating cancer patient acceptance of Whole Body MRI.
    Oliveri S; Pricolo P; Pizzoli S; Faccio F; Lampis V; Summers P; Petralia G; Pravettoni G
    Clin Imaging; 2018; 52():246-251. PubMed ID: 30170274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary observations regarding the expectations, acceptability and satisfaction of whole-body MRI in self-referring asymptomatic subjects.
    Busacchio D; Mazzocco K; Gandini S; Pricolo P; Masiero M; Summers PE; Pravettoni G; Petralia G
    Br J Radiol; 2021 Feb; 94(1118):20191031. PubMed ID: 33237810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perceived patient burden and acceptability of whole body MRI for staging lung and colorectal cancer; comparison with standard staging investigations.
    Evans RE; Taylor SA; Beare S; Halligan S; Morton A; Oliver A; Rockall A; Miles A
    Br J Radiol; 2018 Jun; 91(1086):20170731. PubMed ID: 29528257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of patient preference for either whole body magnetic resonance imaging (WB-MRI) or CT/ PET-CT for staging colorectal or lung cancer.
    Miles A; Evans RE; Halligan S; Beare S; Bridgewater J; Goh V; Janes SM; Navani N; Oliver A; Morton A; Morris S; Rockall A; Taylor SA;
    J Med Imaging Radiat Oncol; 2020 Aug; 64(4):537-545. PubMed ID: 32410378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient centered radiology: investigating 3 Tesla whole body MRI acceptance in cancer patients.
    Rossi A; Prochowski Iamurri A; Diano D; Oboldi D; Sintuzzi E; Maurizio L; Andalò A; Cavallucci M; Ferroni F; Amadori E; Barone D; Petralia G
    Radiol Med; 2023 Aug; 128(8):960-969. PubMed ID: 37395842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic bone imaging in patients with prostate cancer: patient experience and acceptance of NaF-PET/CT, choline-PET/CT, whole-body MRI, and bone SPECT/CT.
    Dyrberg E; Larsen EL; Hendel HW; Thomsen HS
    Acta Radiol; 2018 Sep; 59(9):1119-1125. PubMed ID: 29313360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Streamlining staging of lung and colorectal cancer with whole body MRI; study protocols for two multicentre, non-randomised, single-arm, prospective diagnostic accuracy studies (Streamline C and Streamline L).
    Taylor SA; Mallett S; Miles A; Beare S; Bhatnagar G; Bridgewater J; Glynne-Jones R; Goh V; Groves AM; Janes SM; Koh DM; Morris S; Morton A; Navani N; Oliver A; Padhani AR; Punwani S; Rockall AG; Halligan S
    BMC Cancer; 2017 May; 17(1):299. PubMed ID: 28464835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychological characteristics and satisfaction for the whole-body MRI in cancer screening.
    Busacchio D; Mazzoni D; Mazzocco K; Pricolo P; Summers PE; Petralia G; Pravettoni G
    Psychol Health Med; 2023 Feb; 28(2):548-554. PubMed ID: 36148490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Staging of colon cancer: whole-body MRI vs. whole-body PET-CT--initial clinical experience.
    Squillaci E; Manenti G; Mancino S; Cicciò C; Calabria F; Danieli R; Schillaci O; Simonetti G
    Abdom Imaging; 2008; 33(6):676-88. PubMed ID: 18373114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient deprivation and perceived scan burden negatively impact the quality of whole-body MRI.
    Evans REC; Taylor SA; Kalasthry J; Sakai NS; Miles A;
    Clin Radiol; 2020 Apr; 75(4):308-315. PubMed ID: 31836179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient satisfaction with ultrasound, whole-body CT and whole-body diffusion-weighted MRI for pre-operative ovarian cancer staging: a multicenter prospective cross-sectional survey.
    Pinto P; Valentin L; Borčinová M; Wiesnerová M; Filip F; Burgetova A; Masek M; Lambert L; Chiappa V; Franchi D; Testa AC; Moro F; Avesani G; Panico C; Alessi S; Pricolo P; Vigorito R; Calareso G; Kocian R; Slama J; Fagotti A; Urbinati AMV; Signorelli M; Bertolina F; Cibula D; Fischerova D
    Int J Gynecol Cancer; 2024 Jun; 34(6):871-878. PubMed ID: 38531539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole-body magnetic resonance imaging (WB-MRI) for cancer screening in asymptomatic subjects of the general population: review and recommendations.
    Zugni F; Padhani AR; Koh DM; Summers PE; Bellomi M; Petralia G
    Cancer Imaging; 2020 May; 20(1):34. PubMed ID: 32393345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic performance of FDG-PET/MRI and WB-DW-MRI in the evaluation of lymphoma: a prospective comparison to standard FDG-PET/CT.
    Herrmann K; Queiroz M; Huellner MW; de Galiza Barbosa F; Buck A; Schaefer N; Stolzman P; Veit-Haibach P
    BMC Cancer; 2015 Dec; 15():1002. PubMed ID: 26699124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Staging performance of whole-body DWI, PET/CT and PET/MRI in invasive ductal carcinoma of the breast.
    Catalano OA; Daye D; Signore A; Iannace C; Vangel M; Luongo A; Catalano M; Filomena M; Mansi L; Soricelli A; Salvatore M; Fuin N; Catana C; Mahmood U; Rosen BR
    Int J Oncol; 2017 Jul; 51(1):281-288. PubMed ID: 28535000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole-body MRI for the staging and follow-up of patients with metastasis.
    Schmidt GP; Reiser MF; Baur-Melnyk A
    Eur J Radiol; 2009 Jun; 70(3):393-400. PubMed ID: 19457631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole-body magnetic resonance imaging as surveillance for subsequent malignancies in preadolescent, adolescent, and young adult survivors of germline retinoblastoma: An update.
    Friedman DN; Hsu M; Moskowitz CS; Francis JH; Lis E; Fleischut MH; Oeffinger KC; Walsh M; Tonorezos ES; Sklar CA; Abramson DH; Dunkel IJ
    Pediatr Blood Cancer; 2020 Jul; 67(7):e28389. PubMed ID: 32386119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient experience and perceived acceptability of whole-body magnetic resonance imaging for staging colorectal and lung cancer compared with current staging scans: a qualitative study.
    Evans R; Taylor S; Janes S; Halligan S; Morton A; Navani N; Oliver A; Rockall A; Teague J; Miles A;
    BMJ Open; 2017 Sep; 7(9):e016391. PubMed ID: 28882915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole body magnetic resonance imaging (WB-MRI) and brain MRI baseline surveillance in TP53 germline mutation carriers: experience from the Li-Fraumeni Syndrome Education and Early Detection (LEAD) clinic.
    Bojadzieva J; Amini B; Day SF; Jackson TL; Thomas PS; Willis BJ; Throckmorton WR; Daw NC; Bevers TB; Strong LC
    Fam Cancer; 2018 Apr; 17(2):287-294. PubMed ID: 28988289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole-body magnetic resonance imaging for detection of skeletal metastases in children and young people with primary solid tumors - systematic review.
    Smets AM; Deurloo EE; Slager TJE; Stoker J; Bipat S
    Pediatr Radiol; 2018 Feb; 48(2):241-252. PubMed ID: 29151119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole-body magnetic resonance imaging (WB-MRI) in oncology: an Italian survey.
    Albano D; Stecco A; Micci G; Sconfienza LM; Colagrande S; Reginelli A; Grassi R; Carriero A; Midiri M; Lagalla R; Galia M
    Radiol Med; 2021 Feb; 126(2):299-305. PubMed ID: 32572763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.